+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Cardiac Pacemaker Market Size, Trends & Growth Opportunity, By Type, By End-User, and By Region and Forecast till 2027.

  • PDF Icon

    Report

  • February 2022
  • Region: Global
  • Qualiket Research
  • ID: 5548472
The Cardiac Pacemaker Market is expected to grow at a CAGR of 4.3%
, from USD 5.07 billion in 2020 to USD 7.54 billion in 2027.

A pacemaker is a small electrical device that is used to treat arrhythmias in people who have an irregular heartbeat. Tachycardia and bradycardia are the two types of arrhythmias. Tachycardia is when the heart beat is too fast, and bradycardia is when the heart beat is too slow. Arrhythmia occurs when the heart is unable to pump enough blood to the rest of the body, resulting in fatigue and fainting.

Drivers:

The growing prevalence of cardiovascular disorders in developed countries, high disease occurrence in underdeveloped countries, various supportive government initiatives, and non-government organisation funding are all driving the global cardiac pacemaker market. Advanced diagnostics, a favourable reimbursement scenario for treatment, and cost-effective measures taken by various governments are also driving the cardiac pacemaker market.

Restraints:

On the other hand, the high cost of cardiac drugs and pacemakers is expected to stifle market expansion. The cardiac pacemakers market is expected to be challenged by unfavourable reimbursement scenarios, particularly in developing countries.

Impact of Covid-19

The COVID-19 pandemic is expected to cause a slowdown in the market for cardiac pacemakers. Many countries have suffered and continue to suffer significant economic and healthcare burdens as a result of the high transmission rate and lack of treatment. Many countries have gone into lockdown, suspending trade with other countries, imposing travel restrictions, and so on, causing major companies' market capitalizations to plummet around the world. The American College of Surgeons and the American Society of Anaesthesiologists also recommended a 14-day period of sustained reduction in the rate of new COVID-19 cases before elective surgery could resume.

Market Segmentation

  • Segmentation By Type: Global Cardiac Pacemaker Market is classified on the basis of Type into Implantable and External.
  • Segmentation By End-User: Global Cardiac Pacemaker Market is classified on the basis of End-User into Clinics and Hospitals, Ambulatory Surgical Centres, and Cardiac Care Centres.
  • Segmentation By Region: Global Cardiac Pacemaker Market is classified on the basis of Region into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Competitive Landscape: Medtronic’s, St.Jude Medical Inc., Boston Scientific Corporation, BIOTRONIK SE & Co. KG, Lepu Medical Technology Co ltd., MEDICOWEB, Pacetronix ltd., LivaNova Plc., and Osypka Medical GmbH

Industrial Developments

  • Medtronic Private Limited will launch Azure Pacemaker BlueSync technology in India in October 2020. Patients' smartphones and tablets can communicate directly with this technology.
  • The US Food and Drug Administration approved Medtronic PLC's Leadless Micra AV, the world's smallest pacemaker with atrioventricular (AV) synchrony, in February 2020.
  • Abbott Laboratories received FDA approval for its Gallant line in July 2020, which includes an implantable cardioverter-defibrillator and a cardiovascular resynchronization treatment defibrillator with Bluetooth technology.
  • In October 2020, Medtronic Private Limited launched the Azure Pacemaker BlueSync innovation in India, which allows patients' pacemakers to communicate directly with their phones and tablets.
  • In January 2021, Boston Scientific Corporation announced an agreement to acquire Preventice Solutions, a distant heart observing engineer.

Market Taxonomy


By Type

  • Implantable
  • Single Chamber
  • Dual Chamber
  • Biventricular
  • External

By End-user

  • Clinics and Hospitals
  • Ambulatory Surgical Centres
  • Cardiac Care Centres

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Key Questions Addressed by the Report

  • What are the Key Opportunities in Global Cardiac Pacemaker Market?
  • What will be the growth rate from 2020 to 2027?
  • Which segment/region will have highest growth?
  • What are the factors that will impact/drive the Market?
  • What is the competitive Landscape in the Industry?
  • What is the role of key players in the value chain?
Frequently Asked Questions about the Global Cardiac Pacemaker Market

What is the estimated value of the Global Cardiac Pacemaker Market?

The Global Cardiac Pacemaker Market was estimated to be valued at $24.3 Billion in 2020.

What is the growth rate of the Global Cardiac Pacemaker Market?

The growth rate of the Global Cardiac Pacemaker Market is 6.2%, with an estimated value of $37 Billion by 2027.

What is the forecasted size of the Global Cardiac Pacemaker Market?

The Global Cardiac Pacemaker Market is estimated to be worth $37 Billion by 2027.

Who are the key companies in the Global Cardiac Pacemaker Market?

Key companies in the Global Cardiac Pacemaker Market include Medtronic’s, St.Jude Medical Inc., Boston Scientific Corporation, BIOTRONIK SE & Co. KG, Lepu Medical Technology Co ltd., MEDICOWEB, Pacetronix ltd. and Osypka Medical GmbH.

Table of Contents

1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Cardiac Pacemaker Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5. Global Cardiac Pacemaker Market, By Type
5.1 Y-o-Y Growth Comparison, By Type
5.2 Cardiac Pacemaker Market Share Analysis, By Type
5.3 Cardiac Pacemaker Market Size and Forecast, By Type
5.3.1 Implantable
5.3.2 External
6. Global Cardiac Pacemaker Market, By End-User
6.1 Y-o-Y Growth Comparison, By End-User
6.2 Cardiac Pacemaker Market Share Analysis, By End-User
6.3 Cardiac Pacemaker Market Size and Forecast, By End-User
6.3.1 Clinics and Hospitals
6.3.2 Ambulatory Surgical Centres
6.3.3 Cardiac Care Centres
7. Global Cardiac Pacemaker Market, By Region
7.1 Cardiac Pacemaker Market Share Analysis, By Region
7.2 Cardiac Pacemaker Market Size and Forecast, By Region
7.3 Cardiac Pacemaker Market Size and Forecast, By Region
8. North America Cardiac Pacemaker Analysis and Forecast (2021-2027)
8.1 Introduction
8.2 North America Cardiac Pacemaker Market Share Analysis, By Type
8.3 North America Cardiac Pacemaker Market Size and Forecast, By End-User
8.4 North America Cardiac Pacemaker Market Size and Forecast, By Country
8.4.1 US
8.4.2 Canada
9. Europe Cardiac Pacemaker Market Analysis and Forecast (2021-2027)
9.1 Introduction
9.2 Europe Cardiac Pacemaker Market Share Analysis, By Type
9.3 Europe Cardiac Pacemaker Market Size and Forecast, By End-User
9.4 Europe Cardiac Pacemaker Market Size and Forecast, By Country
9.4.1 UK
9.4.2 Germany
9.4.3 France
9.4.4 Italy
9.4.5 Spain
9.4.6 Netherland
10. Asia Pacific Cardiac Pacemaker Market Analysis and Forecast (2021-2027)
10.1 Introduction
10.2 Asia Pacific Cardiac Pacemaker Market Share Analysis, By Type
10.3 Asia Pacific Cardiac Pacemaker Market Size and Forecast, By End-User
10.4 Asia Pacific Cardiac Pacemaker Market Size and Forecast, By Country
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
11. Latin America Cardiac Pacemaker Market Analysis and Forecast (2021-2027)
11.1 Introduction
11.2 Latin America Cardiac Pacemaker Market Share Analysis, By Type
11.3 Latin America Cardiac Pacemaker Market Size and Forecast, By End-User
11.4 Latin America Cardiac Pacemaker Market Size and Forecast, By Country
11.4.1 Brazil
11.4.2 Rest of Latin America
12 Middle East & Africa Cardiac Pacemaker Market Analysis and Forecast (2021-2027)
12.1 Introduction
12.2 Middle East & Africa Cardiac Pacemaker Market Share Analysis, By Type
12.3 Middle East & Africa Cardiac Pacemaker Market Size and Forecast, By End-User
12.4 Middle East & Africa Cardiac Pacemaker Market Size and Forecast, By Country
12.4.1 Saudi Arabia
12.4.2 UAE
12.4.3. Egypt
12.4.4. Kuwait
12.4.5. South Africa
13 Competitive Analysis
13.1 Competition Dashboard
13.2 Market share Analysis of Top Vendors
13.3 Key Development Strategies
14. Company Profiles
14.1 Medtronic’s
14.1.1 Overview
14.1.2 Offerings
14.1.3 Key Financials
14.1.4 Business Segment & Geographic Overview
14.1.5 Key Market Developments
14.1.6 Key Strategies
14.2 St.Jude Medical Inc
14.2.1 Overview
14.2.2 Offerings
14.2.3 Key Financials
14.2.4 Business Segment & Geographic Overview
14.2.5 Key Market Developments
14.2.6 Key Strategies
14.3 Boston Scientific Corporation
14.3.1 Overview
14.3.2 Offerings
14.3.3 Key Financials
14.3.4 Business Segment & Geographic Overview
14.3.5 Key Market Developments
14.3.6 Key Strategies
14.4 BIOTRONIK SE & Co. KG
14.4.1 Overview
14.4.2 Offerings
14.4.3 Key Financials
14.4.4 Business Segment & Geographic Overview
14.4.5 Key Market Developments
14.4.6 Key Strategies
14.5 Lepu Medical Technology Co ltd.
14.5.1 Overview
14.5.2 Offerings
14.5.3 Key Financials
14.5.4 Business Segment & Geographic Overview
14.5.5 Key Market Developments
14.5.6 Key Strategies
14. MEDICOWEB
14.6.1 Overview
14.6.2 Offerings
14.6.3 Key Financials
14.6.4 Business Segment & Geographic Overview
14.6.5 Key Market Developments
14.6.6 Key Strategies

Companies Mentioned

  • Medtronic’s
  • St.Jude Medical Inc.
  • Boston Scientific Corporation
  • BIOTRONIK SE & Co. KG
  • Lepu Medical Technology Co ltd.
  • MEDICOWEB
  • Pacetronix ltd.
  • LivaNova Plc.
  • Osypka Medical GmbH